디지털 만성질환 관리 시장 보고서(2026년)

Digital chronic disease management refers to the application of digital health technologies to monitor, manage, and support individuals living with long-term chronic health conditions. Its primary purpose is to facilitate continuous patient monitoring, improve treatment adherence, strengthen patient engagement, and reduce hospital visits through proactive, personalized care management.

The primary disease types of digital chronic disease management include musculoskeletal disorders, diabetes, cardiovascular diseases, chronic respiratory diseases, obesity and metabolic disorders, hypertension, cancer, and mental health and behavioral disorders. Musculoskeletal disorders refer to long-term conditions affecting muscles, bones, and joints that require continuous monitoring and digital intervention. These solutions use technologies including mobile applications, telehealth services, wearable devices, and health management platforms and are deployed through web-based, cloud-based, and on-premises systems. They are applied in population health management, remote patient monitoring, medication adherence management, care coordination, and lifestyle and wellness management, serving end users including patients, healthcare providers, payors, and pharmaceutical companies.

Tariffs are influencing the digital chronic disease management market by increasing the cost of imported wearable devices, remote monitoring equipment, healthcare sensors, and digital health infrastructure required for chronic disease management programs. This is creating cost pressures for remote patient monitoring, medication adherence management, and lifestyle and wellness management applications, particularly in regions dependent on imported healthcare technologies such as Asia-Pacific and Latin America. Technology segments including wearable devices, telehealth services, and health management platforms are most affected due to global supply chain dependencies. However, tariffs are also encouraging local manufacturing, regional supplier diversification, and increased investment in domestic digital health infrastructure ecosystems, creating long-term resilience in the market.

The digital chronic disease management market size has grown rapidly in recent years. It will grow from $8.28 billion in 2025 to $9.42 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to rising prevalence of chronic diseases worldwide, increasing healthcare expenditure on long term disease management, growing demand for preventive healthcare services, expansion of telehealth adoption across healthcare systems, increasing focus on reducing hospital admissions and healthcare costs.

The digital chronic disease management market size is expected to see rapid growth in the next few years. It will grow to $15.6 billion in 2030 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to growing demand for continuous patient monitoring solutions, increasing adoption of value based healthcare models, expansion of home healthcare and virtual care services, rising investment in digital health ecosystems, increasing emphasis on patient centric chronic care management. Major trends in the forecast period include increasing adoption of personalized care plans for chronic disease management, growing use of remote patient monitoring programs to reduce hospital readmissions, rising focus on medication adherence tracking and patient engagement solutions, expansion of home based chronic disease management services and virtual care models, increasing integration of multidisciplinary care coordination for long term disease management.

The increasing adoption of telehealth services is expected to propel the growth of the digital chronic disease management market going forward. Telehealth services refer to the delivery of healthcare consultations, monitoring, diagnosis, and patient engagement through digital communication technologies such as video conferencing platforms, remote monitoring systems, and mobile health applications. The increasing adoption of telehealth services is driven by the growing demand for convenient and accessible healthcare, as patients and healthcare providers seek faster remote consultations and continuous care management. Digital chronic disease management supports telehealth services by enabling remote monitoring, continuous patient engagement, personalized treatment support, and real-time management of chronic conditions such as diabetes, hypertension, and cardiovascular diseases. For instance, in April 2023, according to FAIR Health Inc., a US-based nonprofit organization, national telehealth utilization increased by 7.3%, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the increasing adoption of telehealth services is driving the growth of the digital chronic disease management market.

Leading companies operating in the digital chronic disease management market are focusing on developing innovative products, such as AI-powered care tools, to enhance remote patient monitoring, improve personalized treatment delivery, support continuous patient engagement, and optimize chronic disease outcomes. AI-powered care tools are intelligent digital healthcare solutions designed to analyze patient health data, provide virtual care assistance, deliver personalized therapy recommendations, and support remote chronic disease management. For example, in February 2025, Hinge Health, a US-based digital healthcare company, launched AI-powered care tools, including Movement Analysis and the Robin AI Care Assistant, designed to support musculoskeletal chronic disease management. The platform utilizes computer vision technology and AI-driven virtual assistance to deliver personalized exercise guidance, monitor patient progress remotely, and improve accessibility to digital physical therapy and chronic pain management services.

In February 2025, Teladoc Health Inc., a US-based telemedicine and virtual healthcare company, acquired Catapult Health LLC for $70 million. Through this acquisition, Teladoc Health aimed to strengthen its chronic condition management and preventive care capabilities by integrating at-home diagnostic testing, virtual wellness evaluations, and early disease detection services into its digital healthcare ecosystem. Catapult Health LLC is a US-based digital healthcare company specializing in preventive care, virtual health assessments, chronic disease risk identification, and remote patient engagement solutions.

Major companies operating in the digital chronic disease management market are International Business Machines Corporation; F. Hoffmann-La Roche Ltd.; Bayer Aktiengesellschaft; Koninklijke Philips N.V.; Medtronic plc; AstraZeneca PLC; NTT DATA Group Corporation; Epic Systems Corporation; Teladoc Health Inc.; DexCom Inc.; Abbott Laboratories; Health Catalyst Inc.; AptarGroup Inc.; Hinge Health Inc.; ScienceSoft USA Corporation; Omada Health Inc.; WellDoc Inc.; Virta Health Corp.; Glooko Inc.; DarioHealth Corp.; Credo Health Services Pvt. Ltd.; ResMed Inc.; Biofourmis

North America was the largest region in the digital chronic disease management market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital chronic disease management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the digital chronic disease management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital chronic disease management market includes revenues earned by entities by providing services such as chronic care coordination, digital therapeutics support, health coaching, patient engagement programs, AI-driven disease monitoring, and data analytics services. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital chronic disease management market also includes sales of continuous glucose monitors, smart blood pressure monitors, pulse oximeters, and connected inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The digital chronic disease management market research report is one of a series of new reports from The Business Research Company that provides digital chronic disease management market statistics, including digital chronic disease management industry global market size, regional shares, competitors with a digital chronic disease management market share, detailed digital chronic disease management market segments, market trends and opportunities, and any further data you may need to thrive in the digital chronic disease management industry. This digital chronic disease management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Digital Chronic Disease Management Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses digital chronic disease management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital chronic disease management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital chronic disease management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Disease Type: Musculoskeletal Disorders; Diabetes; Cardiovascular Diseases; Chronic Respiratory Diseases; Obesity And Metabolic Disorders; Hypertension; Cancer; Mental Health And Behavioral Disorders
• 2) By Technology: Mobile Applications; Telehealth Services; Wearable Devices; Health Management Platforms
• 3) By Deployment Mode: Web Based; Cloud Based; On Premise
• 4) By Application: Population Health Management; Remote Patient Monitoring; Medication Adherence Management; Care Coordination; Lifestyle And Wellness Management
• 5) By End User: Patients; Healthcare Providers; Payors; Pharmaceutical Companies
• Subsegments:
• 1) By Musculoskeletal Disorders: Sports Injuries; Osteoarthritis; Rheumatoid Arthritis; Osteoporosis; Chronic Back Pain; Joint Disorders; Muscular Disorders; Spine Disorders
• 2) By Diabetes: Diabetic Kidney Disease; Type One Diabetes; Type Two Diabetes; Gestational Diabetes; Prediabetes; Insulin Resistance Disorders; Diabetic Neuropathy; Diabetic Retinopathy
• 3) By Cardiovascular Diseases: Cardiomyopathy; Coronary Artery Disease; Heart Failure; Arrhythmia; Stroke; Peripheral Artery Disease; Congenital Heart Disease; Ischemic Heart Disease
• 4) By Chronic Respiratory Diseases: Allergic Respiratory Disorders; Chronic Obstructive Pulmonary Disease; Asthma; Pulmonary Fibrosis; Sleep Apnea; Bronchitis; Emphysema; Cystic Fibrosis
• 5) By Obesity And Metabolic Disorders: Dyslipidemia; Obesity; Metabolic Syndrome; Hyperlipidemia; Fatty Liver Disease; Thyroid Disorders; Polycystic Ovary Syndrome; Insulin Resistance
• 6) By Hypertension: Gestational Hypertension; Primary Hypertension; Secondary Hypertension; Resistant Hypertension; Pulmonary Hypertension; Isolated Systolic Hypertension; Malignant Hypertension; White Coat Hypertension
• 7) By Cancer: Pancreatic Cancer; Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Blood Cancer; Skin Cancer
• 8) By Mental Health And Behavioral Disorders: Obsessive Compulsive Disorder; Depression; Anxiety Disorders; Bipolar Disorder; Schizophrenia; Substance Use Disorders; Eating Disorders; Post Traumatic Stress Disorder
• Companies Mentioned: International Business Machines Corporation; F. Hoffmann-La Roche Ltd.; Bayer Aktiengesellschaft; Koninklijke Philips N.V.; Medtronic plc; AstraZeneca PLC; NTT DATA Group Corporation; Epic Systems Corporation; Teladoc Health Inc.; DexCom Inc.; Abbott Laboratories; Health Catalyst Inc.; AptarGroup Inc.; Hinge Health Inc.; ScienceSoft USA Corporation; Omada Health Inc.; WellDoc Inc.; Virta Health Corp.; Glooko Inc.; DarioHealth Corp.; Credo Health Services Pvt. Ltd.; ResMed Inc.; Biofourmis
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Digital Chronic Disease Management Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Digital Chronic Disease Management Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Digital Chronic Disease Management Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Digital Chronic Disease Management Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Biotechnology, Genomics & Precision Medicine
  • 4.1.5 Immersive Technologies (AR/VR/XR) & Digital Experiences
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Personalized Care Plans For Chronic Disease Management
  • 4.2.2 Growing Use Of Remote Patient Monitoring Programs To Reduce Hospital Readmissions
  • 4.2.3 Rising Focus On Medication Adherence Tracking And Patient Engagement Solutions
  • 4.2.4 Expansion Of Home Based Chronic Disease Management Services And Virtual Care Models
  • 4.2.5 Increasing Integration Of Multidisciplinary Care Coordination For Long Term Disease Management

5. Digital Chronic Disease Management Market Analysis Of End Use Industries

• 5.1 Patients
• 5.2 Healthcare Providers
• 5.3 Payors
• 5.4 Pharmaceutical Companies
• 5.5 Other End Users

6. Digital Chronic Disease Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Digital Chronic Disease Management Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Digital Chronic Disease Management PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Digital Chronic Disease Management Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Digital Chronic Disease Management Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Digital Chronic Disease Management Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Digital Chronic Disease Management Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Digital Chronic Disease Management Market Segmentation

• 9.1. Global Digital Chronic Disease Management Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Musculoskeletal Disorders, Diabetes, Cardiovascular Diseases, Chronic Respiratory Diseases, Obesity And Metabolic Disorders, Hypertension, Cancer, Mental Health And Behavioral Disorders
• 9.2. Global Digital Chronic Disease Management Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Mobile Applications, Telehealth Services, Wearable Devices, Health Management Platforms
• 9.3. Global Digital Chronic Disease Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Web Based, Cloud Based, On Premise
• 9.4. Global Digital Chronic Disease Management Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Population Health Management, Remote Patient Monitoring, Medication Adherence Management, Care Coordination, Lifestyle And Wellness Management
• 9.5. Global Digital Chronic Disease Management Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Patients, Healthcare Providers, Payors, Pharmaceutical Companies
• 9.6. Global Digital Chronic Disease Management Market, Sub-Segmentation Of Musculoskeletal Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sports Injuries, Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Chronic Back Pain, Joint Disorders, Muscular Disorders, Spine Disorders
• 9.7. Global Digital Chronic Disease Management Market, Sub-Segmentation Of Diabetes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diabetic Kidney Disease, Type One Diabetes, Type Two Diabetes, Gestational Diabetes, Prediabetes, Insulin Resistance Disorders, Diabetic Neuropathy, Diabetic Retinopathy
• 9.8. Global Digital Chronic Disease Management Market, Sub-Segmentation Of Cardiovascular Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cardiomyopathy, Coronary Artery Disease, Heart Failure, Arrhythmia, Stroke, Peripheral Artery Disease, Congenital Heart Disease, Ischemic Heart Disease
• 9.9. Global Digital Chronic Disease Management Market, Sub-Segmentation Of Chronic Respiratory Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Allergic Respiratory Disorders, Chronic Obstructive Pulmonary Disease, Asthma, Pulmonary Fibrosis, Sleep Apnea, Bronchitis, Emphysema, Cystic Fibrosis
• 9.10. Global Digital Chronic Disease Management Market, Sub-Segmentation Of Obesity And Metabolic Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dyslipidemia, Obesity, Metabolic Syndrome, Hyperlipidemia, Fatty Liver Disease, Thyroid Disorders, Polycystic Ovary Syndrome, Insulin Resistance
• 9.11. Global Digital Chronic Disease Management Market, Sub-Segmentation Of Hypertension, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gestational Hypertension, Primary Hypertension, Secondary Hypertension, Resistant Hypertension, Pulmonary Hypertension, Isolated Systolic Hypertension, Malignant Hypertension, White Coat Hypertension
• 9.12. Global Digital Chronic Disease Management Market, Sub-Segmentation Of Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pancreatic Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Skin Cancer
• 9.13. Global Digital Chronic Disease Management Market, Sub-Segmentation Of Mental Health And Behavioral Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Obsessive Compulsive Disorder, Depression, Anxiety Disorders, Bipolar Disorder, Schizophrenia, Substance Use Disorders, Eating Disorders, Post Traumatic Stress Disorder

10. Digital Chronic Disease Management Market Regional And Country Analysis

• 10.1. Global Digital Chronic Disease Management Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Digital Chronic Disease Management Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Digital Chronic Disease Management Market

• 11.1. Asia-Pacific Digital Chronic Disease Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Digital Chronic Disease Management Market

• 12.1. China Digital Chronic Disease Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Digital Chronic Disease Management Market

• 13.1. India Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Digital Chronic Disease Management Market

• 14.1. Japan Digital Chronic Disease Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Digital Chronic Disease Management Market

• 15.1. Australia Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Digital Chronic Disease Management Market

• 16.1. Indonesia Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Digital Chronic Disease Management Market

• 17.1. South Korea Digital Chronic Disease Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Digital Chronic Disease Management Market

• 18.1. Taiwan Digital Chronic Disease Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Digital Chronic Disease Management Market

• 19.1. South East Asia Digital Chronic Disease Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Digital Chronic Disease Management Market

• 20.1. Western Europe Digital Chronic Disease Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Digital Chronic Disease Management Market

• 21.1. UK Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Digital Chronic Disease Management Market

• 22.1. Germany Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Digital Chronic Disease Management Market

• 23.1. France Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Digital Chronic Disease Management Market

• 24.1. Italy Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Digital Chronic Disease Management Market

• 25.1. Spain Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Digital Chronic Disease Management Market

• 26.1. Eastern Europe Digital Chronic Disease Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Digital Chronic Disease Management Market

• 27.1. Russia Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Digital Chronic Disease Management Market

• 28.1. North America Digital Chronic Disease Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Digital Chronic Disease Management Market

• 29.1. USA Digital Chronic Disease Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Digital Chronic Disease Management Market

• 30.1. Canada Digital Chronic Disease Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Digital Chronic Disease Management Market

• 31.1. South America Digital Chronic Disease Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Digital Chronic Disease Management Market

• 32.1. Brazil Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Digital Chronic Disease Management Market

• 33.1. Middle East Digital Chronic Disease Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Digital Chronic Disease Management Market

• 34.1. Africa Digital Chronic Disease Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Digital Chronic Disease Management Market, Segmentation By Disease Type, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Digital Chronic Disease Management Market Regulatory and Investment Landscape

36. Digital Chronic Disease Management Market Competitive Landscape And Company Profiles

• 36.1. Digital Chronic Disease Management Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Digital Chronic Disease Management Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Digital Chronic Disease Management Market Company Profiles
  • 36.3.1. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

37. Digital Chronic Disease Management Market Other Major And Innovative Companies

• AstraZeneca PLC, NTT DATA Group Corporation, Epic Systems Corporation, Teladoc Health Inc., DexCom Inc., Abbott Laboratories, Health Catalyst Inc., AptarGroup Inc., Hinge Health Inc., ScienceSoft USA Corporation, Omada Health Inc., WellDoc Inc., Virta Health Corp., Glooko Inc., DarioHealth Corp.

38. Global Digital Chronic Disease Management Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Digital Chronic Disease Management Market

41. Digital Chronic Disease Management Market High Potential Countries, Segments and Strategies

• 41.1 Digital Chronic Disease Management Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Digital Chronic Disease Management Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Digital Chronic Disease Management Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer